tiprankstipranks
Prescient Therapeutics Limited (AU:PTX)
ASX:PTX
Australian Market

Prescient Therapeutics Limited (PTX) Income Statement

Compare
10 Followers

Prescient Therapeutics Limited Income Statement

Last quarter (Q4 2024), Prescient Therapeutics Limited's total revenue was AU$1.77M, an increase of 69.32% from the same quarter last year. In Q4, Prescient Therapeutics Limited's net income was AU$-4.62M. See Prescient Therapeutics Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
AU$ 3.71MAU$ 2.43MAU$ 1.89MAU$ 1.19MAU$ 1.03M
Gross Profit
AU$ 3.71MAU$ 2.43MAU$ 1.89MAU$ 1.19MAU$ 1.03M
Operating Expenses
AU$ 10.90MAU$ 9.88MAU$ 7.10MAU$ 5.43MAU$ 4.49M
Depreciation and Amortization
AU$ 717.00AU$ 2.09KAU$ 1.40KAU$ 474.00AU$ 904.00
EBITDA
AU$ -7.19MAU$ -7.46MAU$ -5.21MAU$ -4.24MAU$ -3.46M
Operating Income
AU$ -7.19MAU$ -9.89MAU$ -7.10MAU$ -5.43MAU$ -4.49M
Other Income/Expenses
AU$ -4.76MAU$ 513.36KAU$ -1.66MAU$ -1.09MAU$ -885.59K
Pretax Income
AU$ -11.95MAU$ -9.37MAU$ -6.87MAU$ -5.33MAU$ -4.35M
Net Income
AU$ -8.24MAU$ -7.00MAU$ -5.12MAU$ -4.15MAU$ -3.32M
Per Share Metrics
AU$ ―AU$ ―AU$ ―AU$ ―AU$ ―
Basic EPS
AU$ -0.01AU$ -0.01AU$ -0.01AU$ -0.01AU$ -0.01
Diluted EPS
AU$ -0.01AU$ -0.01AU$ -0.01AU$ -0.01AU$ -0.01
Weighted Average Shares Outstanding
805.36M 727.53M 647.80M 611.80M 394.26M
Weighted Average Shares Outstanding (Diluted)
805.31M 727.53M 647.80M 611.80M 394.26M
Currency in AUD

Prescient Therapeutics Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis